Evidence map›Paper›PMID 37050035›Full record

ArticleMolecules (Basel, Switzerland)2023

Evaluating the Application Potential of a Recombinant

Zhi-Jian Guo, Yan Liu, Jia-Yi Yang, Meng-Yuan Jin, Pei-Wen Mao, Xuan-Wei Zhou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Mid-Infrared Spectroscopic Study of Cultivating Medicinal FungiJournal of fungi (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zhi-Jian GuoSchool of Agriculture and Biology, Engineering Research Center of Therapeutic Antibody (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China.
Yan LiuSchool of Agriculture and Biology, Engineering Research Center of Therapeutic Antibody (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China.
Jia-Yi YangSchool of Agriculture and Biology, Engineering Research Center of Therapeutic Antibody (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China.
Meng-Yuan JinSchool of Agriculture and Biology, Engineering Research Center of Therapeutic Antibody (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China.
Pei-Wen MaoSchool of Agriculture and Biology, Engineering Research Center of Therapeutic Antibody (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China.
Xuan-Wei ZhouSchool of Agriculture and Biology, Engineering Research Center of Therapeutic Antibody (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China.ORCID 0000-0002-3993-6346
Shanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the application potential of a recombinant fungal immunomodulatory protein from

Indexed as

GanodermaMelanoma, ExperimentalReishiAnimalsAntioxidantsCell Line, TumorHumansMelaninsMiceMonophenol MonooxygenaseRecombinant ProteinsAntioxidantsMelaninsMonophenol MonooxygenaseRecombinant Proteinsantioxidant activitymelaninrecombinant FIP-glu (rFIP-glu)tyrosinasewhitening potency

Identifiers

PMID37050035
PMCPMC10096787
OpenAlexW4362666015

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.